MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

07 Feb 2022 Evaluate
The December 2021 quarter revenue stood at Rs. 813.67 millions, up 11.79% as compared to Rs. 727.88 millions during the corresponding quarter last year.The Company to register a -38.04%  fall in the net profit for the quarter ended December 2021.The Operating Profit of the company witnessed a decrease to 164.54 millions from 254.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 813.67 727.88 11.79 2357.73 1834.19 28.54 2552.08 1521.81 67.70
Other Income 44.07 36.48 20.81 142.16 87.56 62.36 115.21 33.35 245.46
PBIDT 164.54 254.58 -35.37 659.37 618.97 6.53 852.31 238.71 257.05
Interest 4.16 3.68 13.04 11.88 15.14 -21.53 18.40 22.53 -18.33
PBDT 160.38 250.90 -36.08 647.49 603.83 7.23 833.91 216.18 285.75
Depreciation 19.04 18.62 2.26 57.93 55.43 4.51 73.94 72.65 1.78
PBT 141.34 232.28 -39.15 589.56 548.40 7.51 759.97 143.53 429.49
TAX 32.84 57.18 -42.57 145.68 136.61 6.64 205.28 37.49 447.56
Deferred Tax -4.17 5.38 -177.51 4.67 12.51 -62.67 14.58 -11.95 -222.01
PAT 108.50 175.10 -38.04 443.88 411.79 7.79 554.69 106.04 423.10
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 20.22 34.98 -42.18 27.97 33.75 -17.13 33.40 15.69 112.91
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..